Search

Your search keyword '"Wilcox, Mark H."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Wilcox, Mark H." Remove constraint Author: "Wilcox, Mark H." Topic antibiotics Remove constraint Topic: antibiotics
34 results on '"Wilcox, Mark H."'

Search Results

4. Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model.

5. Omadacycline and Clostridioides difficile : A Systematic Review of Preclinical and Clinical Evidence.

8. Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.

9. The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.

10. Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies.

11. Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.

12. Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.

13. In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.

14. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics.

15. Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series.

16. A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1.

17. Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.

18. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.

19. Role of cephalosporins in the era of Clostridium difficile infection.

20. Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.

21. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.

22. Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.

23. Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.

24. Clostridium difficile infection: new developments in epidemiology and pathogenesis.

25. 700. Safety and Efficacy of Omadacycline in Patients with Diabetes in Phase 3 Clinical Studies.

26. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis.

27. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

28. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

29. Future gazing in the management of multiply drug-resistant Gram-positive infection.

30. The tide of antimicrobial resistance and selection

31. Tigecycline: A Viewpoint by Mark H. Wilcox.

32. Valuing antibiotics: The role of the hospital clinician.

33. Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe.

34. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.

Catalog

Books, media, physical & digital resources